Evidence map›Paper›PMID 39729261›Full record

ReviewInternal and emergency medicine2025

Eosinophilic oesophagitis in adults: from symptoms to therapeutic options.

Carlo Maria Rossi, Marco Vincenzo Lenti, Giovanni Santacroce, Stefania Merli, Alessandro Vanoli, Antonio Di Sabatino

Abstract readReview
PubMed Publisher
In one paragraph

Review in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Eosinophilic gastrointestinal diseases.Nature reviews. Disease primers · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carlo Maria RossiDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.ORCID 0000-0003-1314-361X
Marco Vincenzo LentiDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.ORCID 0000-0002-6654-4911
Giovanni SantacroceDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.ORCID 0000-0002-0544-0414
Stefania MerliFirst Department of Internal Medicine, Clinica Medica I, Fondazione IRCCS Policlinico San Matteo, Università Di Pavia, Viale Golgi 19, 27100, Pavia, Italy.ORCID 0000-0003-1677-5778
Alessandro VanoliAnatomic Pathology Unit, IRCCS San Matteo, Pavia, Italy.ORCID 0000-0002-2976-7032
Antonio Di SabatinoDepartment of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy. a.disabatino@smatteo.pv.it.ORCID 0000-0002-0302-8645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophilic oesophagitis (EoE) is a chronic and progressive immune-mediated condition, typically affecting young atopic male adults and potentially leads to organ dysfunction and fibrosis. The clinical spectrum widely varies -from non-troublesome dysphagia to food impaction- and hence the rate of misdiagnosis and diagnostic delay are high, especially when presenting with minor symptoms, such as heartburn and acid regurgitation. There have been several major therapeutic breakthroughs for the management of EoE in recent years. Highly effective conventional agents with oesophagus-specific formulations (i.e. orodispersible budesonide) and a biological agent (i.e. dupilumab) now have a formal indication. Oesophageal dilation may be indicated in case of strictures, which are more common in longstanding and untreated disease. Therefore, the early diagnosis of this disorder and specialist referral is if of great importance. The evaluation of alarm signs and typical presentation patterns should allow a more straightforward recognition. The emergency and internal medicine doctors should actively be involved in this process and take part to the multidisciplinary care of patients with EoE, to allow better patient care and clinical outcomes.

Indexed as

Eosinophilic EsophagitisAdultAntibodies, Monoclonal, HumanizedBudesonideHumansMaleAntibodies, Monoclonal, HumanizedBudesonideClinicDiagnosisEosinophilTherapy

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.